|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Prevention |
| Condition: |
Influenza |
| Interventions: |
Device: Surgical mask Device: N95 mask |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| 1. Surgical | surgical mask |
| 2. N95 Respirator | N95 respirator |
| 1. Surgical | 2. N95 Respirator | |
|---|---|---|
| STARTED | 225 | 221 |
| COMPLETED | 212 | 210 |
| NOT COMPLETED | 13 | 11 |
| Withdrawal by Subject | 9 | 7 |
| Lost to Follow-up | 4 | 4 |
Baseline Characteristics
| Description | |
|---|---|
| 1. Surgical | surgical mask |
| 2. N95 Respirator | N95 respirator |
| 1. Surgical | 2. N95 Respirator | Total | |
|---|---|---|---|
|
Number of Participants
[units: participants] |
225 | 221 | 446 |
|
Age
[units: participants] |
|||
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 225 | 221 | 446 |
| >=65 years | 0 | 0 | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
36.5 ± 10.6 | 35.8 ± 10.6 | 36.2 ± 10.6 |
|
Gender
[units: participants] |
|||
| Female | 212 | 208 | 420 |
| Male | 13 | 13 | 26 |
|
Region of Enrollment
[units: participants] |
|||
| Canada | 225 | 221 | 446 |
Outcome Measures
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Dr. Mark Loeb, Department of Pathology and Molecular Medicine, McMaster University, Hamilton ON |
| ClinicalTrials.gov Identifier: | NCT00756574 History of Changes |
| Other Study ID Numbers: | 6273-15-2008 |
| Study First Received: | September 19, 2008 |
| Results First Received: | July 15, 2009 |
| Last Updated: | July 15, 2009 |
| Health Authority: | Canada: Health Canada |